NO823265L - Fremgangsmaate ved fremstilling av 7-brom-5-(2-halogenfenyl)-1h-2,3-dihydro-1,4-benzodiazepinderivater - Google Patents

Fremgangsmaate ved fremstilling av 7-brom-5-(2-halogenfenyl)-1h-2,3-dihydro-1,4-benzodiazepinderivater

Info

Publication number
NO823265L
NO823265L NO823265A NO823265A NO823265L NO 823265 L NO823265 L NO 823265L NO 823265 A NO823265 A NO 823265A NO 823265 A NO823265 A NO 823265A NO 823265 L NO823265 L NO 823265L
Authority
NO
Norway
Prior art keywords
dihydro
bromo
halophenyl
benzodiazepines
halogenphenyl
Prior art date
Application number
NO823265A
Other languages
English (en)
Other versions
NO157698B (no
NO157698C (no
Inventor
Horst Zeugner
Michael Ruhland
Hans Liepmann
Wolfgang Milkowski
Herbert Muesch
Original Assignee
Kali Chemie Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kali Chemie Pharma Gmbh filed Critical Kali Chemie Pharma Gmbh
Publication of NO823265L publication Critical patent/NO823265L/no
Publication of NO157698B publication Critical patent/NO157698B/no
Publication of NO157698C publication Critical patent/NO157698C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02Muscle relaxants, e.g. for tetanus or cramps
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D243/00Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/141,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
    • C07D243/161,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D245/00Heterocyclic compounds containing rings of more than seven members having two nitrogen atoms as the only ring hetero atoms
    • C07D245/04Heterocyclic compounds containing rings of more than seven members having two nitrogen atoms as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • C07D245/06Heterocyclic compounds containing rings of more than seven members having two nitrogen atoms as the only ring hetero atoms condensed with carbocyclic rings or ring systems condensed with one six-membered ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
NO823265A 1981-09-30 1982-09-28 Analogifremgangsmaate ved fremstilling av terapeutisk aktive 7-brom-5-(2-halogenfenyl)-1h-2,3-dihydro-1,4-benzodiazepinforbindelser. NO157698C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19813138769 DE3138769A1 (de) 1981-09-30 1981-09-30 7-brom-5-(2-halogenphenyl)-1h-2,3-dihydro-1,4- benzodiazepin-verbindungen sowie verfahren und zwischenprodukte zu ihrer herstellung und diese verbindungen enthaltende arzneimittel

Publications (3)

Publication Number Publication Date
NO823265L true NO823265L (no) 1983-04-05
NO157698B NO157698B (no) 1988-01-25
NO157698C NO157698C (no) 1988-05-04

Family

ID=6142952

Family Applications (1)

Application Number Title Priority Date Filing Date
NO823265A NO157698C (no) 1981-09-30 1982-09-28 Analogifremgangsmaate ved fremstilling av terapeutisk aktive 7-brom-5-(2-halogenfenyl)-1h-2,3-dihydro-1,4-benzodiazepinforbindelser.

Country Status (20)

Country Link
US (1) US4505908A (no)
EP (1) EP0075855B1 (no)
JP (1) JPS5867678A (no)
AT (1) ATE17123T1 (no)
AU (1) AU553689B2 (no)
CA (1) CA1196635A (no)
DD (1) DD203907A5 (no)
DE (2) DE3138769A1 (no)
DK (1) DK156065C (no)
ES (1) ES8306126A1 (no)
FI (1) FI68047C (no)
GR (1) GR77652B (no)
HU (1) HU189179B (no)
IE (1) IE53937B1 (no)
IL (1) IL66890A (no)
NO (1) NO157698C (no)
NZ (1) NZ202036A (no)
PH (1) PH18102A (no)
PT (1) PT75553B (no)
ZA (1) ZA827140B (no)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3221402A1 (de) * 1982-06-05 1983-12-08 Kali-Chemie Pharma Gmbh, 3000 Hannover 5-phenyl-1,4-benzodiazepine enthaltende analgetisch wirksame pharmazeutische zubereitungen
CN1382205A (zh) * 1999-08-27 2002-11-27 宝洁公司 快速作用的制剂组分、使用该制剂组分的组合物和洗衣方法
DE60028387T2 (de) * 1999-08-27 2007-05-24 The Procter & Gamble Company, Cincinnati Bleichverstärkende verbindungen, zusammensetzungen und waschverfahren
US6903060B1 (en) 1999-08-27 2005-06-07 Procter & Gamble Company Stable formulation components, compositions and laundry methods employing same
US7109156B1 (en) 1999-08-27 2006-09-19 Procter & Gamble Company Controlled availability of formulation components, compositions and laundry methods employing same
US6818607B1 (en) * 1999-08-27 2004-11-16 Procter & Gamble Company Bleach boosting components, compositions and laundry methods
US6821935B1 (en) 1999-08-27 2004-11-23 Procter & Gamble Company Color safe laundry methods employing zwitterionic formulation components
US6825160B1 (en) 1999-08-27 2004-11-30 Procter & Gamble Company Color safe laundry methods employing cationic formulation components
AU6935500A (en) 1999-08-27 2001-03-26 Procter & Gamble Company, The Stability enhancing formulation components, compositions and laundry methods employing same
US7557076B2 (en) 2002-06-06 2009-07-07 The Procter & Gamble Company Organic catalyst with enhanced enzyme compatibility
US7169744B2 (en) 2002-06-06 2007-01-30 Procter & Gamble Company Organic catalyst with enhanced solubility
US20050113246A1 (en) * 2003-11-06 2005-05-26 The Procter & Gamble Company Process of producing an organic catalyst
AR051659A1 (es) * 2005-06-17 2007-01-31 Procter & Gamble Una composicion que comprende un catalizador organico con compatibilidada enzimatica mejorada
US9700443B2 (en) 2015-06-12 2017-07-11 Abbott Cardiovascular Systems Inc. Methods for attaching a radiopaque marker to a scaffold

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2520937C3 (de) * 1975-05-10 1978-10-12 Kali-Chemie Ag, 3000 Hannover 7-Brom-1 -methyl^-alkoxymethyl-S-(2-halogenphenyl)-lH-23-dihydro-l,4benzodiazepinderivate, deren Säureadditionssalze und pharmazeutische Präparate
DE2265371C3 (de) * 1972-05-03 1980-12-11 Kali-Chemie Ag, 3000 Hannover N-(3-Benzoylaminopropyl)-aniline
US4244869A (en) * 1972-05-03 1981-01-13 Kali-Chemie A.G. Benzodiazepine derivatives and process of making them
DE2353160C2 (de) * 1973-05-02 1986-07-17 Kali-Chemie Ag, 3000 Hannover 5-Phenyl-2,3-dihydro-1H-1,4-benzodiazepine, ihre Säureadditionssalze und diese Verbindungen enthaltende Arzneimittel

Also Published As

Publication number Publication date
GR77652B (no) 1984-09-25
FI823338L (fi) 1983-03-31
PT75553A (en) 1982-10-01
FI823338A0 (fi) 1982-09-29
DK156065C (da) 1989-11-13
IE53937B1 (en) 1989-04-26
ES515774A0 (es) 1983-05-01
DD203907A5 (de) 1983-11-09
PH18102A (en) 1985-03-20
ATE17123T1 (de) 1986-01-15
DK156065B (da) 1989-06-19
IE822362L (en) 1983-03-30
IL66890A0 (en) 1982-12-31
CA1196635A (en) 1985-11-12
PT75553B (en) 1984-12-12
ES8306126A1 (es) 1983-05-01
AU8883882A (en) 1983-04-14
NO157698B (no) 1988-01-25
EP0075855B1 (de) 1985-12-27
EP0075855A2 (de) 1983-04-06
FI68047C (fi) 1985-07-10
ZA827140B (en) 1983-07-27
EP0075855A3 (en) 1983-06-15
DE3138769A1 (de) 1983-04-14
NZ202036A (en) 1985-02-28
DK431782A (da) 1983-03-31
NO157698C (no) 1988-05-04
IL66890A (en) 1985-11-29
FI68047B (fi) 1985-03-29
US4505908A (en) 1985-03-19
AU553689B2 (en) 1986-07-24
DE3268156D1 (en) 1986-02-06
JPS5867678A (ja) 1983-04-22
HU189179B (en) 1986-06-30
JPH0433791B2 (no) 1992-06-04

Similar Documents

Publication Publication Date Title
NO823265L (no) Fremgangsmaate ved fremstilling av 7-brom-5-(2-halogenfenyl)-1h-2,3-dihydro-1,4-benzodiazepinderivater
NO163820C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive oksadiazolylbenzodiazepinderivater.
NO303015B1 (no) AnalogifremgangsmÕte for fremstilling av terapeutisk aktive 4-alkylimidazolderivater
EP0551963A3 (en) Use of heterocyclic derivatives for the manufacture of medicaments
NO871867D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive heterocykliske kondenserte tricykliske forbindelser.
ZA874385B (en) Hydroxypyrazole derivatives,their preparation and their use against microorganism
DK231686A (da) Oxadiazolylimidazobenzodiazepinforbindelse, farmaceutisk praeparat indeholdende samme, fremgangsmaade til fremstilling af forbindelsen og fremgangsmaade til behandling af en centralnervesystemsygdom
DE58907706D1 (de) 4,5,7,8-Tetrahydro-6H-thiazolo[5,4-d]azepine, ihre Herstellung und ihre Verwendung als Arzneimittel.
AU536912B2 (en) Benzothiazole derivatives
FI961246A0 (fi) Radiofarmaseutika preparationer av radiojoderade bentsodiatsepinanaloger och deras anvaendning i diaknostik
ATE15802T1 (de) 2-acylaminomethyl-1,4-benzodiazepin-verbindunge sowie verfahren und zwischenprodukte zu ihrer herstellung und diese verbindungen enthaltende arzneimittel.
ATE22081T1 (de) Substituierte thienobenzodiazepinone, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel.
DK231586A (da) Oxadiazolylimidazobenzodiazepinforbindelse, farmaceutisk praeparat indeholdende samme, fremgangsmaade til fremstilling af forbindelsen og fremgangsmaade til behandling af en centralnervesystemsygdom
NO158675C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive morfantridin-derivater.
ZA873224B (en) 3-amino-dihydropyridines,a process for their preparation,and their use in medicaments
PT77466A (de) Neue 4-hydroxy-2h-1,2-benzothiazin-3-carboxamid-1,1-dioxide verfahren zu ihrer herstellung ihre verwendung und diese verbindungen enthaltende arzneimittel
SE8005317L (sv) Forfarande for framstellning av bensodiazepinderivat
SE8002523L (sv) 5-aryl-1-(2-oxazolin-2-yl)-1h-1,4-bensodiazepiner och beslektade foreningar
SE8704331L (sv) Kondenserade, cykliska triazolderivat
JPS5283775A (en) 1,2,4-benzothiazine derivative